Product
Clotting factor concentrates (CFC) or bypassing agents (BPA)
2 clinical trials
2 indications
Indication
HemophiliaIndication
Hemophilia AClinical trial
A Phase 3, Single-arm, Multicenter, Multinational, Open-label, One-way Crossover Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged ≥ 12 Years With Severe Hemophilia A or B With or Without Inhibitory Antibodies to Factor VIII or IXStatus: Recruiting, Estimated PCD: 2026-04-15
Clinical trial
An Open-label, Single-arm Treatment Study to Investigate the Safety and Tolerability of Switching From Emicizumab to Fitusiran Prophylaxis in Male Participants Aged ≥18 Years of Age With Severe Hemophilia A, With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2026-09-19